Issues
Analysis
Acid attack victim who considered 'assisted dying' may finally get the help she needs
Cassy Cooke
·Spotlight Articles
What women need to know about the FDA’s newly approved vaginal ring
A new method of birth control has just been approved by the FDA. Annovera is a vaginal ring which provides a year of birth control, and is being heralded as an important step towards expanding contraceptive options for women. Women insert the ring into their vagina, where it remains for three weeks, and then remove it for one week. It is a hormonal contraceptive that underwent 17 clinical trials before being approved. For most women in the clinical trials, Annovera worked well and was effective at preventing pregnancy. According to the FDA, the most common side effects were headaches and nausea. On the surface, it seems like a great new medical advancement — but it should come as no surprise that there are significant risks, and women deserve to know the facts.
While there have been numerous clinical trials, women with a BMI of 29 or higher were
These side effects are not unlike those of other birth control methods, which raises the question if Annovera will be something with which women are truly satisfied. Most women stop using birth control within two years, often because of negative side effects.
Also concerning is the fact that the FDA worked with the Population Council to get Annovera approved. The Population Council is already talking about making Annovera available around the world. The Council is, in reality, a eugenics organization that heavily promotes not just birth control, but abortion.
“This approval is a key first step toward introducing this product globally and better meeting the sexual and reproductive health needs of women, men and young people in the U.S. and around the world,” said Jim Sailer, executive director of the Center for Biomedical Research at the Population Council. “We are grateful to the dozens of researchers who have worked on this product, the donors who have funded its development, and most of all, to the thousands of women who volunteered to participate in clinical trials and made this all possible.”
While preventing unplanned pregnancy is a positive thing, women deserve better than birth control that puts their bodies at risk — especially a birth control pushed by an organization with a history of eugenics.
Live Action News is pro-life news and commentary from a pro-life perspective.
Our work is possible because of our donors. Please consider giving to further our work of changing hearts and minds on issues of life and human dignity.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
What women need to know about the FDA’s newly approved vaginal ring
A new method of birth control has just been approved by the FDA. Annovera is a vaginal ring which provides a year of birth control, and is being heralded as an important step towards expanding contraceptive options for women. Women insert the ring into their vagina, where it remains for three weeks, and then remove it for one week. It is a hormonal contraceptive that underwent 17 clinical trials before being approved. For most women in the clinical trials, Annovera worked well and was effective at preventing pregnancy. According to the FDA, the most common side effects were headaches and nausea. On the surface, it seems like a great new medical advancement — but it should come as no surprise that there are significant risks, and women deserve to know the facts.
While there have been numerous clinical trials, women with a BMI of 29 or higher were not “adequately evaluated.” And among women who were studied, there were still numerous risks that could be concerning. Like most hormonal birth control, Annovera’s most serious risk is that of blood clots, a risk that is even higher if a woman has recently had an
Analysis
Cassy Cooke
·
International
Cassy Cooke
·
Politics
Cassy Cooke
·
Analysis
Cassy Cooke
·
International
Cassy Cooke
·
Human Interest
Nancy Flanders
·
Issues
Bridget Sielicki
·
Issues
Bridget Sielicki
·
Issues
Sheena Rodriguez
·
Human Interest
Nancy Flanders
·These side effects are not unlike those of other birth control methods, which raises the question if Annovera will be something with which women are truly satisfied. Most women stop using birth control within two years, often because of negative side effects.
Also concerning is the fact that the FDA worked with the Population Council to get Annovera approved. The Population Council is already talking about making Annovera available around the world. The Council is, in reality, a eugenics organization that heavily promotes not just birth control, but abortion.
“This approval is a key first step toward introducing this product globally and better meeting the sexual and reproductive health needs of women, men and young people in the U.S. and around the world,” said Jim Sailer, executive director of the Center for Biomedical Research at the Population Council. “We are grateful to the dozens of researchers who have worked on this product, the donors who have funded its development, and most of all, to the thousands of women who volunteered to participate in clinical trials and made this all possible.”
While preventing unplanned pregnancy is a positive thing, women deserve better than birth control that puts their bodies at risk — especially a birth control pushed by an organization with a history of eugenics.
Live Action News is pro-life news and commentary from a pro-life perspective.
Our work is possible because of our donors. Please consider giving to further our work of changing hearts and minds on issues of life and human dignity.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Issues
Sheena Rodriguez
·Politics
Cassy Cooke
·
